Evidence map›Paper›PMID 27249108›Full record

ArticleScientific reports2016

ATAC-seq on biobanked specimens defines a unique chromatin accessibility structure in naïve SLE B cells.

Christopher D Scharer, Emily L Blalock, Benjamin G Barwick, Robert R Haines, Chungwen Wei, Ignacio Sanz, Jeremy M Boss

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Jump-starting the T cell response in established tumors.bioRxiv : the preprint server for biology · 2026
    Article
  7. Symbiosis with and mimicry of corals were facilitated by immune gene loss and body remodeling in the pygmy seahorse.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Measuring B Cell Chromatin Accessibility by One-Step ATAC-seq.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Christopher D ScharerDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Emily L BlalockDepartment of Rheumatology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Benjamin G BarwickDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Robert R HainesDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Chungwen WeiDepartment of Rheumatology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Ignacio SanzDepartment of Rheumatology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Jeremy M BossDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Emory University · US

Funding

Regulation of B cell Responses in SLE and Other Autoimmune DiseasesU19AI110483 · NIAID · EMORY UNIVERSITY · PI JEREMY M. BOSS · 2014 to 2026
$76.6M
PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM008490 · NIGMS · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 1993 to 2022
$8.0M
Regulation of MHC Class II GenesR01GM047310 · NIGMS · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 1993 to 2015
$4.6M
A Model System for the Study of Human B-cell ToleranceR37AI049660 · NIAID · UNIVERSITY OF ROCHESTER · PI SANZ, IGNACIO E. · 2010 to 2019
$3.7M
Epigenetic Programming of B cell Terminal DifferentiationF31AI112261 · NIAID · EMORY UNIVERSITY · PI BARWICK, BENJAMIN GABRIEL · 2014 to 2016
$120k
NIAID NIH HHS F31 AI112261NIAID NIH HHS R37 AI049660NIAID NIH HHS U19 AI110483NIGMS NIH HHS R01 GM047310NIGMS NIH HHS T32 GM008490
6 · The paper itself

Abstract

Biobanking is a widespread practice for storing biological samples for future studies ranging from genotyping to RNA analysis. However, methods that probe the status of the epigenome are lacking. Here, the framework for applying the Assay for Transposase Accessible Sequencing (ATAC-seq) to biobanked specimens is described and was used to examine the accessibility landscape of naïve B cells from Systemic Lupus Erythematosus (SLE) patients undergoing disease flares. An SLE specific chromatin accessibility signature was identified. Changes in accessibility occurred at loci surrounding genes involved in B cell activation and contained motifs for transcription factors that regulate B cell activation and differentiation. These data provide evidence for an altered epigenetic programming in SLE B cells and identify loci and transcription factor networks that potentially impact disease. The ability to determine the chromatin accessibility landscape and identify cis-regulatory elements has broad application to studies using biorepositories and offers significant advantages to improve the molecular information obtained from biobanked samples.

Indexed as

Biological AssayEpigenesis, GeneticBlood BanksB-LymphocytesChromatinChromosome MappingCryopreservationCryoprotective AgentsDimethyl SulfoxideDNA Transposable ElementsGenetic LociGenotypeHumansLupus Erythematosus, SystemicSequence Analysis, DNATransposasesChromatinCryoprotective AgentsDimethyl SulfoxideDNA Transposable ElementsTransposases

Identifiers

PMID27249108
PMCPMC4888756
OpenAlexW2409562298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.